Peptide myths spread because each one holds a grain of truth. Peptides aren't steroids. They aren't new, either: insulin is a peptide, and it has been treating diabetes since 1922. And "natural" tells you nothing about what's in a vial or how much of it is safe. Below are ten claims people repeat online, each graded against the study or rule that can actually answer it.

This page covers peptides as a group. The drug-specific claims have their own ledgers for semaglutide and tirzepatide.

Peptide myths: how the grades work

Supported means the evidence backs the claim as stated. Partly means one piece holds up. Not supported means the claim goes further than the evidence does. Unknown means nobody has tested it well enough to say.

1. "Peptides are just steroids."

Not supported. A peptide is a short chain of amino acids, the building blocks of protein. One pharmacology review defines therapeutic peptides as chains of fewer than 50 (Diao and Meibohm, Clinical Pharmacokinetics, 2013). Federal law defines an anabolic steroid as a drug "chemically and pharmacologically related to testosterone" (21 U.S.C. § 802). Different molecules, different receptors. Peptides vs steroids lays the two side by side.

2. "Peptides are a new, experimental fad."

Partly. The category is old. A 1922 paper from Toronto reported the first insulin treatment of people with diabetes (Banting and colleagues, Canadian Medical Association Journal). By 2021, more than 80 peptide drugs had reached the market (Muttenthaler and colleagues, Nature Reviews Drug Discovery).

The "experimental" half fits many compounds sold online, though. BPC-157 grew out of stomach research published in the early 1990s (Sikirić and colleagues, 1993), and its human data are still thin.

3. "Your body makes peptides, so they're natural and safe."

Not supported. The pancreas makes insulin, and too much of it drops blood sugar dangerously. A CDC-led analysis of 2007–2011 data estimated about 97,600 U.S. emergency visits a year for insulin-related low blood sugar and dosing errors; almost a third ended in a hospital stay (Geller and colleagues, JAMA Internal Medicine, 2014).

"Natural" says nothing about the vial, either. BPC-157 is often sold as natural because its sequence traces to a stomach protein, but the product is a lab-made copy. The BPC-157 myth ledger grades that claim on its own.

4. "Collagen peptides are the same thing as peptide therapy."

Not supported. Collagen peptides are animal protein from skin, bone or cartilage, broken into fragments and sold as supplements, and your gut digests them like other protein. When researchers in Japan tested blood after volunteers swallowed gelatin hydrolysates (the same kind of broken-down collagen), the fragments they found were mostly two amino acids long (Iwai and colleagues, Journal of Agricultural and Food Chemistry, 2005).

A prescribed peptide is one specific sequence aimed at one receptor, or, like tirzepatide, at two, and it's usually injected so it isn't digested. Sharing a word doesn't make them interchangeable.

5. "A bigger dose works faster."

Not supported. More drug mostly means more side effects. In SURMOUNT-1, a 72-week trial of 2,539 adults, the 15 mg tirzepatide group lost 20.9% of body weight on average, against 15.0% at 5 mg: three times the dose, nowhere near three times the result. More people quit over side effects at the higher doses (6.2% at 15 mg, against 4.3% at 5 mg and 2.6% on placebo), and most stomach side effects came during the 20-week climb to full dose (Jastreboff and colleagues, NEJM, 2022).

Mistakes run the same direction. FDA has received reports of people injecting five to 20 times their intended dose of compounded semaglutide, some needing hospital care. Timing depends on the molecule and what is being measured, as how long peptides take to work explains.

6. "A peptide pill or spray works as well as a shot."

Partly. Digestion breaks most swallowed peptides apart before they're absorbed. The Diao and Meibohm review calls their oral bioavailability, the share of a swallowed dose that reaches the blood, "very limited," which is why most peptide medicines are injected.

An oral form can work when it's engineered and tested for that route. The semaglutide tablet needed a purpose-built absorption enhancer called SNAC, and its makers found the effect was specific to that compound (Buckley and colleagues, Science Translational Medicine, 2018). Any other peptide tablet or spray needs absorption data of its own. What bioavailability means explains the idea, and sermorelin tablets shows the gap for one compound.

Not supported. As of September 23, 2026, the day this article was written, FDA had posted warning letters, dated August 24, to online peptide sellers, calling their products unapproved new drugs. A warning letter states FDA's position; it isn't a court ruling. In one letter, FDA said that despite labeling pitched at laboratory use, the seller's website "establishes that your products are intended to be drugs for human use," pointing to bacteriostatic water sold beside a "peptide calculator."

What's inside is a separate problem. When researchers bought semaglutide from online sellers that skipped the prescription, three of six orders arrived. All three contained endotoxin, a bacterial residue that can cause fever, and purity measured 7.7% to 14.4% against a 99% label claim (Ashraf and colleagues, Journal of Medical Internet Research, 2024). Are peptides legal? and gray-market peptides go further.

8. "If a doctor prescribes it, the FDA must have approved it."

Not supported. FDA's own compounding page is blunt: "Compounded drugs are not FDA-approved," which means the agency doesn't verify their safety, effectiveness or quality before they're sold (FDA).

Peptides through Promise are dispensed as compounded medications, which is different from an FDA-approved product: the formulations offered here are not FDA-approved. What the prescription adds is a licensed prescriber who reviewed your history, and a licensed U.S. compounding pharmacy whose label says what's in the vial. A licensed provider may still prescribe a compounded formulation; that decision is between you and your doctor.

9. "There are hundreds of studies, so it's proven."

Not supported. Counting papers isn't counting people. As of September 23, 2026, the day this article was written, one of the most recent tallies came from UCLA surgeons, published August 11 in The American Journal of Sports Medicine: a review of six popular recovery peptides, BPC-157 and TB-500 among them. Two-thirds of the papers (67%) used animals, mostly rats. Human studies were "limited to a handful," most without strong controls, and the claimed recovery benefits "remain unsubstantiated by current human trials" (Tewari and colleagues, 2026).

The feed rarely says so. An August abstract reviewing 239 top social-media posts about peptides, with 10.1 million views between them, found only 12.5% mentioned side effects (Shah and colleagues, Orthopaedic Journal of Sports Medicine, 2026).

10. "Drug tests can't find peptides."

Not supported. As of September 23, 2026, the day this article was written, the World Anti-Doping Agency's (WADA) 2027 Prohibited List, published September 21 and in force from January 1, names "peptides" among its examples of unapproved substances prohibited at all times. WADA's explanatory note adds: "Even if a peptide is not specifically named on the List, utmost caution should be taken as it may still be prohibited and may be harmful to health."

BPC-157 is named outright. TB-500 sits under growth factors, and sermorelin under growth-hormone-releasing hormone analogues. Testing keeps up: one Beijing anti-doping lab validated a single urine method covering 63 small-peptide targets (Liu and colleagues, Drug Testing and Analysis, 2025). The 2027 list explainer has the rest.

What the grades add up to

Most of these claims fail the same way: a real fact asked to carry more than it can. A peptide can be old as a class and new as a compound, natural to your body and still harmful in the wrong amount.

A prescription doesn't make thin evidence thick. What it changes is who's accountable: a provider licensed in your state who reads your history first, a licensed U.S. compounding pharmacy that labels the vial and can trace the lot, and someone to call if something feels off. At Promise, a licensed provider reviews every request, and not everyone qualifies.